Myosin essential light chain in health and disease

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 4, 2007, Pages

  Hernandez, Olga M ^a   Jones, Michelle ^a   Guzman, Georgianna ^a   Szczesna Cordary, Danuta ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cross bridge kinetics; Failing heart; Familial hypertrophic cardiomyopathy; Sarcomeric mutations; Striated muscle contraction; Sudden cardiac death

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN;

ACTIN MYOSIN INTERACTION; ALPHA HELIX; DISEASE SEVERITY; FORCE; GENE MUTATION; HEART MUSCLE CELL; HYPERTROPHIC CARDIOMYOPATHY; KINETICS; MOTOR PERFORMANCE; MUSCLE CONTRACTION; MYOFILAMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; HEART; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOSIN LIGHT CHAINS; PROTEIN CONFORMATION;

EID: 34147155175     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00931.2006     Document Type: Review

References (113)

1. Abdelaziz A, Segaric J, Bartsch H, Petzhold D, Schlegel WP, Kott M, Seefeldt I, Klose J, Bader M, Haase H, Morano I. Functional characterization of the human atrial essential myosin light chain (hALC-1) in a transgenic rat model. J Mol Med 82: 265-274, 2004.
2. Abdelaziz AI, Pagel I, Schlegel WP, Kott M, Monti J, Haase H, Morano I. Human atrial myosin light chain 1 expression attenuates heart failure. Adv Exp Med Biol 565: 283-292; discussion 292, 405-215, 2005.
3. Andreev OA, Borejdo J. Binding of myosin cross-bridges to thin filaments of rabbit skeletal muscle. Biochem Biophys Res Commun 258: 628-631, 1999.
4. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, Barr S, Karim A, Olson TM, Kamisago M, Seidman JG, Seidman CE. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005.
5. Arrell DK, Neverova I, Fraser H, Marban E, Van Eyk JE. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res 89: 480-487, 2001.
6. Auckland LM, Lambert SJ, Cummins P. Cardiac myosin light and heavy chain isotypes in tetralogy of Fallot. Cardiovasc Res 20: 828-836, 1986.
7. Barton PJ, Buckingham ME. The myosin alkali light chain proteins and their genes. Biochem J 231: 249-261, 1985.
8. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. Familial Hypertrophic Cardiomyopathy: from mutations to functional defects. Circ Res 83: 580-593, 1998.
9. Borejdo J, Ushakov DS, Akopova I. Regulatory and essential light chains of myosin rotate equally during contraction of skeletal muscle. Biophys J 82: 3150-3159, 2002.
10. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93: 9067-9072, 1996.
11. Buckingham M, Kelly R, Tajbakhsh S, Zammit P. The formation and maturation of skeletal muscle in the mouse: the myosin MLC1F/3F gene as a molecular model. Acta Physiol Scand 163: S3-S5, 1998.
12. Carafoli E, Santella L, Branca D, Brini M. Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 36: 107-260, 2001.
13. Collins JH. Myosin light chains and troponin C: structural and evolutionary relationships revealed by amino acid sequence comparisons. J Muscle Res Cell Motil 12: 3-25, 1991.
14. Craig R, Woodhead JL. Structure and function of myosin filaments. Curr Opin Struct Biol 16: 204-212, 2006.
15. Cummins P, Price KM, Littler WA. Foetal myosin light chain in human ventricle. J Muscle Res Cell Motil 1: 357-366, 1980.
16. Davis JS, Hassanzadeh S, Winitsky S, Wen H, Aletras A, Epstein ND. A gradient of myosin regulatory light-chain phosphorylation across the ventricular wall supports cardiac torsion. Cold Spring Harb Symp Quant Biol 67: 345-352, 2002.
17. Diffee GM, Nagle DF. Exercise training alters length dependence of contractile properties in rat myocardium. J Appl Physiol 94: 1137-1144, 2003.
18. Diffee GM, Seversen EA, Stein TD, Johnson JA. Microarray expression analysis of effects of exercise training: increase in atrial MLC-1 in rat ventricles. Am J Physiol Heart Circ Physiol 284: H830-H837, 2003.
19. 2+ sensitivity of tension in rat cardiac myocytes. J Appl Physiol 91: 309-315, 2001.
20. Dominguez R, Freyzon Y, Trybus KM, Cohen C. Crystal structure of a vertebrate smooth muscle myosin motor domain and its complex with the essential light chain: visualization of the pre-power stroke state. Cell 94: 559-571, 1998.
21. Dumka D, Talent J, Akopova I, Guzman G, Szczesna-Cordary D, Borejdo J. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on crossbridge kinetics. Am J Physiol Heart Circ Physiol 291: H2098-H2106, 2006.
22. Efimova NN, Stepkowski D, Nieznanska H, Borovikov YS. The shortening of the N-terminus of myosin essential light chain A1 influences the interaction of heavy meromyosin with actin. Biochem Mol Biol Int 46: 1101-1108, 1998.
23. Epstein ND. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. Adv Exp Med Biol 453: 105-114, 1998.
24. Epstein ND, Davis JS. When is a fly in the ointment a solution and not a problem? Circ Res 98: 1110-1112, 2006.
25. Fewell JG, Hewett TE, Sanbe A, Klevitsky R, Hayes E, Warshaw D, Maughan D, Robbins J. Functional significance of cardiac myosin essential light chain isoform switching in transgenic mice. J Clin Invest 101: 2630-2639, 1998.
26. Fodor WL, Darras B, Seharaseyon J, Falkenthal S, Francke U, Vanin EF. Human ventricular/slow twitch myosin alkali light chain gene characterization, sequence, and chromosomal location. J Biol Chem 264: 2143-2149, 1989.
27. Frearson N, Perry SV. Phosphorylation of the light-chain components of myosin from cardiac and red skeletal muscles. Biochem J 151: 99-107, 1975.
28. Gomes AV, Potter JD, Szczesna-Cordary D. The role of troponins in muscle contraction. IUBMB Life 54: 323-333, 2002.
29. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev 80: 853-924, 2000.
30. Grabarek Z. Structural Basis for Diversity of the EF-hand Calcium-binding Proteins. J Mol Biol 359: 509-525, 2006.
31. Haase H, Dobbernack G, Tunnemann G, Karczewski P, Cardoso C, Petzhold D, Schlegel WP, Lutter S, Pierschalek P, Behlke J, Morano I. Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats. FASEB J 20: 865-873, 2006.
32. Henry GD, Winstanley MA, Dalgarno DC, Scott GM, Levine BA, Trayer IP. Characterization of the actin-binding site on the alkali light chain of myosin. Biochim Biophys Acta 830: 233-243, 1985.
33. Houdusse A, Cohen C. Structure of the regulatory domain of scallop myosin at 2 A resolution: implications for regulation. Structure 4: 21-32, 1996.
34. Houdusse A, Kalabokis VN, Himmel D, Szent-Gyorgyi AG, Cohen C. Atomic structure of scallop myosin subfragment S1 complexed with MgADP: a novel conformation of the myosin head. Cell 97: 459-470, 1999.
35. James J, Zhang Y, Wright K, Witt S, Glascock E, Osinska H, Klevitsky R, Martin L, Yager K, Sanbe A, Robbins J. Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy. J Mol Cell Cardiol 34: 873-882, 2002.
36. Jiang P, Song J, Gu G, Slonimsky E, Li E, Rosenthal N. Targeted deletion of the MLC1f/3f downstream enhancer results in precocious MLC expression and mesoderm ablation. Dev Biol 243: 281-293, 2002.
37. Kelly R, Alonso S, Tajbakhsh S, Cossu G, Buckingham M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol 129: 383-396, 1995.
38. Khalina YN, Bartsch H, Petzhold D, Haase H, Podlubnaya ZA, Shpagina MD, Morano I. Reconstitution of ventricular myosin with atrial light chains 1 improves its functional properties. Acta Biochim Pol 52: 443-448, 2005.
39. Komiyama M, Soldati T, von Arx P, Perriard JC. The intracompartmental sorting of myosin alkali light chain isoproteins reflects the sequence of developmental expression as determined by double epitope-tagging competition. J Cell Sci 109: 2089-2099, 1996.
40. Kretsinger RH. Calcium-binding proteins. Annu Rev Biochem 45: 239-266, 1976.
41. Kretsinger RH. Structure and evolution of calcium-modulated proteins. CRC Crit Rev Biochem 8: 119-174, 1980.
42. Kurabayashi M, Komuro I, Tsuchimochi H, Takaku F, Yazaki Y. Molecular cloning and characterization of human atrial and ventricular myosin alkali light chain cDNA clones. J Biol Chem 263: 13930-13936, 1988.
43. Kwon H, Goodwin EB, Nyitray L, Berliner E, O'Neall-Hennessey E, Melandri FD, Szent-Gyorgyi AG. Isolation of the regulatory domain of scallop myosin: role of the essential light chain in calcium binding. Proc Natl Acad Sci USA 87: 4771-4775, 1990.
44. Lee W, Hwang TH, Kimura A, Park SW, Satoh M, Nishi H, Harada H, Toyama J, Park JE. Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy. Am Heart J 141: 184-189, 2001.
45. Lowey S, Waller GS, Trybus KM. Function of skeletal muscle myosin heavy and light chain isoforms by an in vitro motility assay. J Biol Chem 268: 20414-20418, 1993.
46. Lowey S, Waller GS, Trybus KM. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature 365: 454-456, 1993.
47. Maciver SK. Myosin II function in non-muscle cells. Bioessays 18: 179-182, 1996.
48. Maron BJ. The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification. Card Electrophysiol Rev 6: 100-103, 2002.
49. Maron BJ, Bonow RO, Seshagiri TNR, Roberts WC, Epstein SE. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 49: 1838-1848, 1982.
50. Miller MS, Palmer BM, Ruch S, Martin LA, Farman GP, Wang Y, Robbins J, Irving TC, Maughan DW. The essential light chain N-terminal extension alters force and fiber kinetics in mouse cardiac muscle. J Biol Chem 280: 34427-34434, 2005.
51. Milligan RA, Whittaker M, Safer D. Molecular structure of F-actin and location of surface binding sites. Nature 348: 217-221, 1990.
52. Miyanishi T, Ishikawa T, Hayashibara T, Maita T, Wakabayashi T. The two actin-binding regions on the myosin heads of cardiac muscle. Biochemistry 41: 5429-5438, 2002.
53. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H. Sudden death due to troponin T mutations. J Am Coll Cardiol 29: 549-555, 1997.
54. Morano I. Tuning the human heart molecular motors by myosin light chains. J Mol Med 77: 544-555, 1999.
55. Morano I, Haase H. Different actin affinities of human cardiac essential myosin light chain isoforms. FEBS Lett 408: 71-74, 1997.
56. Morano I, Hadicke K, Haase H, Bohm M, Erdmann E, Schaub MC. Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol 29: 1177-1187, 1997.
57. Morano I, Ritter O, Bonz A, Timek T, Vahl CF, Michel G. Myosin light chain-actin interaction regulates cardiac contractility. Circ Res 76: 720-725, 1995.
58. Morano I, Rosch J, Arner A, Ruegg JC. Phosphorylation and thiophosphorylation by myosin light chain kinase: different effects on mechanical properties of chemically skinned ventricular fibers from the pig. J Mol Cell Cardiol 22: 805-813, 1990.
59. Morano M, Zacharzowski U, Maier M, Lange PE, Alexi-Meskishvili V, Haase H, Morano I. Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest 98: 467-473, 1996.
60. Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D, Gillitzer A, Bott-Flugel L, Schomig A, Ungerer M, Laugwitz KL. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci USA 99: 11860-11865, 2002.
61. Nieznanska H, Nieznanski K, Efimova N, Kakol I, Stepkowski D. Dual effect of actin on the accessibility of myosin essential light chain A1 to papain cleavage. Biochim Biophys Acta 1383: 71-81, 1998.
62. Nieznanska H, Nieznanski K, Stepkowski D. The effects of the interaction of myosin essential light chain isoforms with actin in skeletal muscles. Acta Biochim Pol 49: 709-719, 2002.
63. 2+ binding to myosin regulatory light chain affects the conformation of the N-terminus of essential light chain and its binding to actin. Arch Biochem Biophys 417: 153-158, 2003.
64. Olson TM, Karst ML, Whitby FG, Driscoll DJ. Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology. Circulation 105: 2337-2340, 2002.
65. Palmer B. Thick filament proteins and performance in human heart failure. Heart Failure Rev 10: 187-197, 2005.
66. Periasamy M, Wieczorek DF, Nadal-Ginard B. Characterization of a developmentally regulated perinatal myosin heavy-chain gene expressed in skeletal muscle. J Biol Chem 259: 13573-13578, 1984.
67. Pliszka B, Redowicz MJ, Stepkowski D. Interaction of the N-terminal part of the A1 essential light chain with the myosin heavy chain. Biochem Biophys Res Commun 281: 924-928, 2001.
68. Podlubnaya Z, Kakol I, Moczarska A, Stepkowski D, Udaltsov S. Calcium-induced structural changes in synthetic myosin filaments of vertebrate striated muscles. J Struct Biol 127: 1-15, 1999.
69. Podlubnaya ZA, Kakol I, Moczarska A, Stepkowski D, Udaltsov S. Truncation of vertebrate striated muscle myosin light chains disturbs calcium-induced structural transitions in synthetic myosin filaments. J Struct Biol 131: 225-233, 2000.
70. Podlubnaya ZA, Malyshev SL, Nieznanski K, Stepkowski D. Order-disorder structural transitions in synthetic filaments of fast and slow skeletal muscle myosins under relaxing and activating conditions. Acta Biochim Pol 47: 1007-1017, 2000.
71. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63-69, 1996.
72. Poole KJ, Lorenz M, Evans G, Rosenbaum G, Pirani A, Craig R, Tobacman LS, Lehman W, Holmes KC. A comparison of muscle thin filament models obtained from electron microscopy reconstructions and low-angle X-ray fibre diagrams from non-overlap muscle. J Struct Biol 155: 273-284, 2006.
73. 2+ regulation of muscle contraction. Biochemistry 13: 2697-2703, 1974.
74. Price KM, Littler WA, Cummins P. Human atrial and ventricular myosin light-chains subunits in the adult and during development. Biochem J 191: 571-580, 1980.
75. Rarick HM, Opgenorth TJ, von Geldern TW, Wu-Wong JR, Solaro RJ. An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity. J Biol Chem 271: 27039-27043, 1996.
76. Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261: 50-58, 1993.
77. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M, and for the EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227-2232, 2003.
78. Ritter O, Haase H, Schulte HD, Lange PE, Morano I. Remodeling of the hypertrophied human myocardium by cardiac bHLH transcription factors. J Cell Biochem 74: 551-561, 1999.
79. Robert B, Daubas P, Akimenko MA, Cohen A, Garner I, Guenet JL, Buckingham M. A single locus in the mouse encodes both myosin light chains 1 and 3, a second locus corresponds to a related pseudogene. Cell 39: 129-140, 1984.
80. Sanbe A, Gulick J, Fewell J, Robbins J. Examining the in vivo role of the amino terminus of the essential myosin light chain. J Biol Chem 276: 32682-32686, 2001.
81. Sanbe A, Gulick J, Hayes E, Warshaw D, Osinska H, Chan CB, Klevitsky R, Robbins J. Myosin light chain replacement in the heart. Am J Physiol Heart Circ Physiol 279: H1355-H1364, 2000.
82. Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X, Hewett TE, Klevitsky R, Hayes E, Warshaw DM, Robbins J. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 296-302, 2000.
83. 2 terminus of the regulatory light chain by fluorescence resonance energy transfer. J Biol Chem 273: 17671-17679, 1998.
84. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112: 544-552, 2005.
85. Schaub MC, Hirzel HO. Atrial and ventricular isomyosin composition in patients with different forms of cardiac hypertrophy. Basic Res Cardiol 82, Suppl 2: 357-367, 1987.
86. Solaro RJ. Troponin C - troponin I interactions and molecular signalling in cardiac myofilaments. Adv Exp Med Biol 382: 109-115, 1995.
87. Solaro RJ, Rarick HM. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 83: 471-480, 1998.
88. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342: 1778-1785, 2000.
89. Stepkowski D, Efimova N, Paczynska A, Moczarska A, Nieznanska H, Kakol I. The possible role of myosin A1 light chain in the weakening of actin-myosin interaction. Biochim Biophys Acta 1340: 105-114, 1997.
90. Strynadka NC, Cherney M, Sielecki AR, Li MX, Smillie LB, James MN. Structural details of a calcium-induced molecular switch: X-ray crystallographic analysis of the calcium-saturated N-terminal domain of troponin C at 1.75 A resolution. J Mol Biol 273: 238-255, 1997.
91. Sutoh K. An actin-binding site on the 20K fragment of myosin subfragment 1. Biochemistry 21: 4800-4804, 1982.
92. Sweeney HL. Function of the N terminus of the myosin essential light chain of vertebrate striated muscle. Biophys J 68: 112S-S118S; discussion 118S-S119S, 1995.
93. Szczesna D. Regulatory light chains of striated muscle myosin. Structure, function and malfunction Curr Drug Targets. Cardiovasc Haematol Disord 3: 187-197, 2003.
94. 2+-regulation of skeletal muscle contraction. Results Probl Cell Differ 36: 171-190, 2002.
95. Szent-Gyorgyi AG, Szentkiralyi EM. The light chains of scallop myosin as regulatory subunits. J Mol Biol 74: 179-203, 1973.
96. Terrak M, Wu G, Stafford WF, Lu RC, Dominguez R. Two distinct myosin light chain structures are induced by specific variations within the bound IQ motifs-functional implications. EMBO J 22: 362-371, 2003.
97. Timson DJ. Fine tuning the myosin motor: the role of the essential light chain in striated muscle myosin. Biochimie 85: 639-645, 2003.
98. Timson DJ, Trayer HR, Smith KJ, Trayer IP. Size and charge requirements for kinetic modulation and actin binding by alkali 1-type myosin essential light chains. J Biol Chem 274: 18271-18277, 1999.
99. Timson DJ, Trayer HR, Trayer IP. The N-terminus of A1-type myosin essential light chains binds actin and modulates myosin motor function. Eur J Biochem 255: 654-662, 1998.
100. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 58: 447-481, 1996.
101. Trayer HR, Trayer IP. Differential binding of rabbit fast muscle myosin light chain isoenzymes to regulated actin. FEBS Lett 180: 170-173, 1985.
102. Trayer IP, Trayer HR, Levine BA. Evidence that the N-terminal region of A1-light chain of myosin interacts directly with the C-terminal region of actin. A proton magnetic resonance study. Eur J Biochem 164: 259-266, 1987.
103. Trybus KM. Role of myosin light chains. J Muscle Res Cell Motil 15: 587-594, 1994.
104. VanBuren P, Waller GS, Harris DE, Trybus KM, Warshaw DM, Lowey S. The essential light chain is required for full force production by skeletal muscle myosin. Proc Natl Acad Sci USA 91: 12403-12407, 1994.
105. Vemuri R, Lankford EB, Poetter K, Hassanzadeh S, Takeda K, Yu ZX, Ferrans VJ, Epstein ND. The stretch-activation response may be critical to the proper functioning of the mammalian heart. Proc Natl Acad Sci USA 96: 1048-1053, 1999.
106. Wagner PD, Weeds AG. Studies on the role of myosin alkali light chains. Recombination and hybridization of light chains and heavy chains in subfragment-1 preparations. J Mol Biol 109: 455-470, 1977.
107. Waller GS, Ouyang G, Swafford J, Vibert P, Lowey S. A minimal motor domain from chicken skeletal muscle myosin. J Biol Chem 270: 15348-15352, 1995.
108. Weeds AG, Taylor RS. Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin. Nature 257: 54-56, 1975.
109. Wendel B, Reinhard R, Wachtendorf U, Zacharzowsky UB, Osterziel KJ, Schulte HD, Haase H, Hoehe MR, Morano I. The human beta-myosin heavy chain gene: sequence diversity and functional characteristics of the protein. J Cell Biochem 79: 566-575, 2000.
110. Winstanley MA, Trayer HR, Trayer IP. Role of the myosin light chains in binding to actin. FEBS Lett 77: 239-242, 1977.
111. 2+-calmodulin-dependent signaling pathways. FASEB J 19: 503-511, 2005.
112. Xie X, Harrison DH, Schlichting I, Sweet RM, Kalabokis VN, Szent-Gyorgyi AG, Cohen C. Structure of the regulatory domain of scallop myosin at 2.8 A resolution. Nature 368: 306-312, 1994.
113. Yamashita H, Sugiura S, Fujita H, Yasuda S, Nagai R, Saeki Y, Sunagawa K, Sugi H. Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actinmyosin interaction. Cardiovasc Res 60: 580-588, 2003.